NBTY May Sell Debt Amid Junk-Bond Fund Inflows: New Issue Alert
This article is for subscribers only.
NBTY Inc., the maker of Nature’s Bounty and MET-Rx nutritional supplements, may sell notes as deposits in mutual funds investing in high-yield, high-risk debt climb.
NBTY may issue $900 million of bonds in addition to seeking a $1.5 billion term loan and a $200 million revolving line of credit to help pay for its acquisition by Carlyle Group, according to a person familiar with the transaction who declined to be identified because terms aren’t set.